Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 25;13:3371–3381. doi: 10.2147/DMSO.S274534

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Li et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

Basic Research on TCM in the Treatment of Obesity. The three pathways of TCM in obesity treatment to: 1. By affecting the composition of intestinal microflora, regulation of intestinal metabolites (SCFAs, bile acids, and BACC) directly affects the roles of metabolites in obesity or indirectly increases the secretion of hormones by endocrine cells (GLP-1, PYY, and CKK) that regulate the hypothalamus, affect appetite and attenuate obesity. 2. AMPK is activated to regulate lipid metabolism or upregulate BAT-related genes in WAT to promote the browning of WAT and thermogenic fat activation. 3. Directly or indirectly promote fat tissue secretion of leptin, adiponectin, FGF21, GLP-1, and PYY to promote lipid metabolism and/or affect appetite by regulating the hypothalamus.